ARTICLE | Company News
EC approves Eliquis
May 21, 2011 12:19 AM UTC
The European Commission approved Eliquis apixaban from Bristol-Myers Squibb Co. (NYSE:BMY) and partner Pfizer Inc. (NYSE:PFE) to prevent venous thromboembolic events (VTE) in adults who have undergone...